Biden Administration Sets Limits on Use of Short-Term Health Insurance Plans, But States Can Do More to Protect Consumers

A recently proposed federal rule aims to mitigate the harm of short-term insurance plans, products exempt from the Affordable Care Act’s consumer protections. In a post for the Commonwealth Fund, Justin Giovannelli, Kevin Lucia, and Christina L. Goe explain the proposed federal rule and describe what else states can do to further protect their residents.

The Perfect Storm: Misleading Marketing of Limited Benefit Products Continues as Millions Losing Medicaid Search for New Coverage

A massive coverage transition is underway for millions of people who have relied on Medicaid throughout the COVID-19 pandemic. After a three-year pause, states have begun disenrolling residents from Medicaid, leaving millions of people in need of new coverage. A secret shopper study conducted in June 2023 suggests that people losing Medicaid are facing aggressive marketing of limited benefit products.

Surprise Billing: Volume Of Cases Using Independent Dispute Resolution Continues Higher Than Anticipated

The No Surprises Act is largely working as intended to protect patients from unexpected medical bills. However, the rising number of Independent Dispute Resolution (IDR) cases is creating challenges for the health care system. In a post for Health Affairs Forefront, Jack Hoadley and Kevin Lucia evaluate the causes and implications of the increasing number of IDR cases.

July Research Roundup: What We’re Reading

CHIR’s summer reading list includes the latest health policy literature. In July, we read about the disparities in medical debt burdens, policy interventions to reduce choice errors in the Affordable Care Act (ACA) Marketplace, and the affordability of Marketplace health insurance under subsidy expansion.

Early Rate Filings Show Premium Increases, Rising Costs of Care

The Centers for Medicare & Medicaid Services has published proposed rate changes for 2024 Marketplace plans. In some states, insurers submitted rate requests earlier in the summer, alongside justifications for the proposed changes to next year’s premiums. CHIR dug into the rate requests from select states with early rate filing deadlines to see what’s behind the premiums consumers could be facing in 2024, both on- and off-Marketplace.

Tackling Another Public Health Emergency: Recent State and Federal Policies to Increase Opioid Use Disorder Treatment Access

While the federal COVID-19 Public Health Emergency (PHE) ended in May, the PHE declaration for the opioid crisis continues. Opioid overdose deaths remain alarmingly high, and the Biden administration recently bolstered the federal government’s response to the opioid crisis with new proposed rules to strengthen access to treatment. CHIR’s Rachel Swindle and Kristen Ukeomah explore this proposal as well as other recent state and federal policy changes that aim to reduce barriers to evidence-based treatment for opioid use disorder.

The Biden Administration Takes Aim At Medical Financing Products

This month, the Biden administration issued a Request for Information (RFI) on “the scope, prevalence, terms, and impacts” of medical credit cards and other high-cost medical financing products. In a post for Health Affair’s Forefront, CHIR’s Maanasa Kona explains the RFI and outlines some of the risks these products pose for patients.

The opinions expressed here are solely those of the individual blog post authors and do not represent the views of Georgetown University, the Center on Health Insurance Reforms, any organization that the author is affiliated with, or the opinions of any other author who publishes on this blog.